Blood pressure medication recalls
Every Class I, II, and III FDA recall affecting blood pressure medications. Drugs in this category include Lisinopril, Losartan, Amlodipine, Valsartan.
November 27, 20241 recall
June 5, 20241 recall
May 1, 20241 recall
April 10, 20241 recall
January 3, 20241 recall
July 19, 20231 recall
July 12, 20231 recall
February 8, 20231 recall
November 2, 20221 recall
September 21, 20221 recall
How FDA classifies recalls
Class I: The drug may cause serious health consequences or death. Examples include the wrong drug in a bottle, a drug contaminated with bacteria, or a life-threatening allergen not declared on the label.
Class II: The drug may cause temporary or medically reversible adverse health consequences, or the probability of serious consequences is remote. Examples include a dissolution failure, a labeling error that affects dosing, or a nitrosamine impurity above the daily intake limit.
Class III: Use of the drug is unlikely to cause adverse health consequences, but the product violates FDA regulations. Examples include an incorrect tablet count per bottle, minor labeling issues, or packaging defects.
Definitions sourced from FDA Recall Classifications →